Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 102M 91.05M 84M 76.01M 142M 9.68B 144M 1B 400M 5.07B 381M 373M 16.05B | P/E 2026 * |
-5.04x | P/E 2027 * | -79.7x |
|---|---|---|---|---|---|
| Enterprise Value | 102M 91.05M 84M 76.01M 142M 9.68B 144M 1B 400M 5.07B 381M 373M 16.05B | EV / Sales 2026 * |
1.68x | EV / Sales 2027 * | 0.24x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 104M | ||
| +0.34% | +1.12% | +34.75% | +61.06% | 64.14B | ||
| +0.98% | +2.68% | +12.25% | +82.98% | 55.53B | ||
| +1.75% | +2.01% | +13.30% | +103.69% | 53.03B | ||
| -1.43% | -1.17% | +26.27% | +52.86% | 45.99B | ||
| -0.48% | -2.80% | +18.01% | +117.99% | 42.45B | ||
| +0.82% | +1.37% | +227.94% | +922.41% | 40.45B | ||
| -0.26% | -2.57% | +12.55% | +45.18% | 32.25B | ||
| -2.07% | +42.73% | +103.77% | +88.74% | 34.47B | ||
| -0.62% | -2.31% | +22.31% | -11.41% | 24.23B | ||
| Average | -0.86% | +4.29% | +52.35% | +162.61% | 43.62B | |
| Weighted average by Cap. | +0.05% | +3.59% | +49.24% | +160.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.4M 54.1M 49.91M 45.17M 84.46M 5.75B 85.82M 595M 238M 3.01B 227M 222M 9.53B | 431M 386M 356M 323M 603M 41.07B 613M 4.25B 1.7B 21.49B 1.62B 1.58B 68.08B |
| Net income | -41.4M -37.08M -34.21M -30.96M -57.89M -3.94B -58.83M -408M -163M -2.06B -155M -152M -6.53B | -4.5M -4.03M -3.72M -3.37M -6.29M -429M -6.39M -44.36M -17.7M -224M -16.89M -16.53M -710M |
| Net Debt | - | - |
Employees
-
















